Pharma Invest Management SRL
Pharma Invest Management reported total assets of €3.11m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
By total assets for 2025, Pharma Invest Management ranks among the 5,000 largest of the 50,431 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Pharma Invest Management shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +17 % Total assets +139 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Invest Management's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Pharma Invest Management's financial analysis
- Solvency26.4%sector median: 49.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Invest Management
Pharma Invest Management's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0808.104.525
- VAT number
- BE0808104525
- Peppol
- Registered · 0208:0808104525 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Dec 2008
- Registered office
- 4630 Soumagne
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharma Invest Management (SRL) has been based in Soumagne since 2008, active in: business and other management consultancy activities. For 2025, it reports a net profit of 35,265 € and equity of 821,234 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Invest Management
Companies in the same business, of comparable size and area, outside its group.
- PE Consult Business and other management consultancy activities Kapellen · balance sheet €3.29m
- Notaris Samuël Van der Linden Business and other management consultancy activities Diepenbeek · balance sheet €2.74m
- Swings Invest Business and other management consultancy activities Bertem · balance sheet €2.70m
- Eribelle Business and other management consultancy activities Koksijde · balance sheet €2.66m
- Hphold Business and other management consultancy activities Welkenraedt · balance sheet €3.78m
- Titanium Business and other management consultancy activities Aartselaar · balance sheet €2.51m
- Management Services Invest Business and other management consultancy activities Juprelle · balance sheet €2.43m
- Clofini Business and other management consultancy activities Leuven · balance sheet €2.31m
Frequently asked questions about Pharma Invest Management
What is the revenue of Pharma Invest Management?
Pharma Invest Management files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Invest Management?
In Belgium, the VAT number is the company number prefixed with BE: BE0808104525 for Pharma Invest Management, if the company is VAT-registered. Its company number (CBE) is 0808.104.525.
Where is the registered office of Pharma Invest Management?
According to the CBE register, the registered office of Pharma Invest Management is in 4630 Soumagne.
What is the equity of Pharma Invest Management?
At the close of the 2025 financial year, the equity of Pharma Invest Management amounts to 821,234 €, a solvency of 26.4% of total assets.
Who manages Pharma Invest Management?
The register lists 2 active mandates at Pharma Invest Management. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Pharma Invest Management within its sector?
By total assets for 2025, Pharma Invest Management ranks among the 5,000 largest of the 50,431 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of Pharma Invest Management
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →